Subscribe to our newsletter and stay informed

Check out our list of top companies

Check out our carefully compiled lists of the most relevant and impactful companies within their fields.

Check out our list of top unicorns

Read and learn about the biggest companies that various countries have produced, how they made it, and what the future looks like for them.

AI-Powered Eko Health Raises $41M for Early Heart Disease Detection

Eko Health achieved a monumental milestone, a recent $41 million Series D funding round
June 6, 2024

In the annals of medical history, the stethoscope stands as a timeless icon, transforming the way doctors listen to the rhythm of life within their patients' chests. Yet, in the hands of Eko Health, a startup born in 2013, this revered instrument undergoes a digital metamorphosis, ushering in a new era of precision healthcare.

With over 500,000 units sold to healthcare professionals worldwide, Eko's digitally-enhanced stethoscope marries the traditional art of auscultation with the power of artificial intelligence. Armed with a vast repository of chest sounds and electrocardiogram (ECG) data, Eko's algorithms dance through this symphony of medical information, detecting heart conditions with unparalleled accuracy.

Connor Landgraf, Eko Health's visionary CEO, envisions a future where every heartbeat reveals its secrets, thanks to AI-driven insights. "Our mission is simple: to empower healthcare providers with the precision of AI, ensuring timely and accurate diagnoses," Landgraf explains.

In April, Eko's digital stethoscope received the coveted FDA clearance, marking a milestone in the battle against heart disease. With algorithms finely tuned to detect early signs of heart failure and murmurs indicative of valve abnormalities, Eko's technology transcends the limitations of traditional diagnostics.

The company's triumphs in the clinical realm have not gone unnoticed. A recent $41 million Series D funding round, led by industry giants ARTIS Ventures and Highland Capital Partners, propels Eko's mission forward. This infusion of capital paves the way for further innovation, training AI to detect a myriad of pulmonary conditions and expanding the reach of Eko's transformative technology beyond U.S. borders.

Vas Bailey, partner at ARTIS Ventures, speaks from personal experience as he reflects on Eko's potential to rewrite the narrative of cardiac care. "Eko is more than a startup; it's a lifeline," Bailey asserts. With a poignant nod to his own loss, he underscores the profound impact Eko's technology could have on countless lives.

While Eko leads the charge in integrating AI into stethoscopes, it shares the stage with fellow innovators like Ultromics and CardioSignal. Together, these trailblazing startups herald a new dawn in heart healthcare, where AI-driven insights hold the promise of saving lives.

More about:  | |

Last related articles

chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram